oldid78766

SIF Muntenia exits Biofarm with 46% profit

SIF Muntenia has sold its 2% stake in drug producer Biofarm Bucharest, following transactions on the market whereby it collected 4.5 million RON (over 1.2 million euros). The company bought the stake early in 2005, which means it made some 46% off the investme...